Alpha 2.0
Login Register
» Authors » Clement B Ndongmo

Clement B Ndongmo

Explore the profile of Clement B Ndongmo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 256
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Public Health
Top 10 Co-Authors
Andrew C Voetsch
Yen T Duong
Hetal K Patel
Judith D Shang
Bharat S Parekh
Suzue Saito
Katrina Sleeman
Harriet Nuwagaba-Biribonwoha
Daniel B Williams
Kristin Brown
Published In
Emerg Infect Dis
J Acquir Immune Defic Syndr
PLOS Glob Public Health
J Clin Microbiol
AIDS
Affiliations
Soon will be listed here.
Recent Articles
1.
XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillance
Fokam J, Ngoufack Jagni Semengue E, Gouissi Anguechia D, Etame N, Takou D, Mandeng N, et al.
PLOS Glob Public Health . 2024 May; 4(5):e0003153. PMID: 38728356
As of December 2022, Cameroon had observed a slight resurgence of COVID-19, raising concerns on genomic surveillance of related-SARS-CoV-2 variants under circulation. Following a laboratory-based survey, positive SARS-CoV-2 samples detected...
2.
HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia: Analysis of 14 cross-sectional population-based HIV Impact Assessment surveys in sub-Saharan Africa
Edun O, Okell L, Chun H, Bissek A, Ndongmo C, Shang J, et al.
PLOS Glob Public Health . 2024 Apr; 4(4):e0003030. PMID: 38573931
As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV programmes require up-to-date information about evolving HIV risk behaviour and transmission risk, including those with low-level viremia...
3.
Seroprevalence of SARS-CoV-2 in 10 Regional Capitals of Cameroon, October-December 2020
Sachathep K, Duong Y, Reid G, Dokubo E, Shang J, Ndongmo C, et al.
Influenza Other Respir Viruses . 2024 Mar; 18(4):e13267. PMID: 38532666
Background: Cameroon was among the most affected African countries during the first wave of the COVID-19 pandemic; however, the true prevalence of SARS-CoV-2 remains unknown. Methods: From October to December...
4.
Brief Report: Self-Reported HIV-Positive Status but Subsequent HIV-Negative Test Results in Population-Based HIV Impact Assessment Survey Participants-11 Sub-Saharan African Countries, 2015-2018
Logan N, Kilmarx P, Rolle I, Patel H, Duong Y, Lee K, et al.
J Acquir Immune Defic Syndr . 2024 Feb; 95(4):313-317. PMID: 38412045
Background: HIV testing is a critical step to accessing antiretroviral therapy (ART) because early diagnosis can facilitate earlier initiation of ART. This study presents aggregated data of individuals who self-reported...
5.
Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from Cameroon
Fokam J, Essomba R, Njouom R, Okomo M, Eyangoh S, Godwe C, et al.
Sci Rep . 2023 Dec; 13(1):21654. PMID: 38066020
While the SARS-CoV-2 dynamic has been described globally, there is a lack of data from Sub-Saharan Africa. We herein report the dynamics of SARS-CoV-2 lineages from March 2020 to March...
6.
Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015-2019
Currie D, West C, Patel H, Favaloro J, Asiimwe F, Ndagije F, et al.
Emerg Infect Dis . 2023 Oct; 29(11):2325-2334. PMID: 37877591
Identifying persons who have newly acquired HIV infections is critical for characterizing the HIV epidemic direction. We analyzed pooled data from nationally representative Population-Based HIV Impact Assessment surveys conducted across...
7.
Point of Care CD4 Testing in National Household Surveys - Results and Quality Indicators from Eleven Population-Based HIV Impact Assessment (PHIA) Surveys
Birhanu S, Winterhalter F, Stupp P, Cates M, Rottinghaus E, Yavo D, et al.
Microbiol Spectr . 2023 Apr; 11(3):e0314822. PMID: 37071009
Population-based HIV Impact Assessments (PHIAs) are national household (HH) surveys that provide HIV diagnosis and CD4 testing with an immediate return of results. Accurate CD4 results improve HIV-positive participants' clinical...
8.
Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries
Rottinghaus Romano E, Sleeman K, Hall-Eidson P, Zeh C, Bhairavabhotla R, Zhang G, et al.
Emerg Infect Dis . 2022 Dec; 28(13):S59-S68. PMID: 36502414
The US President's Emergency Plan for AIDS Relief (PEPFAR) supports molecular HIV and tuberculosis diagnostic networks and information management systems in low- and middle-income countries. We describe how national programs...
9.
Building on Capacity Established through US Centers for Disease Control and Prevention Global Health Programs to Respond to COVID-19, Cameroon
Dokubo E, Shang J, NDir A, Ndongmo C, Okpu G, Fadil Y, et al.
Emerg Infect Dis . 2022 Dec; 28(13):S181-S190. PMID: 36502395
The COVID-19 pandemic has highlighted the need for resilient health systems with the capacity to effectively detect and respond to disease outbreaks and ensure continuity of health service delivery. The...
10.
Unawareness of HIV Infection Among Men Aged 15-59 Years in 13 Sub-Saharan African Countries: Findings From the Population-Based HIV Impact Assessments, 2015-2019
West C, Chang G, Currie D, Bray R, Kinchen S, Behel S, et al.
J Acquir Immune Defic Syndr . 2021 Jun; 87(Suppl 1):S97-S106. PMID: 34166316
Background: Identifying men living with HIV in sub-Saharan Africa (SSA) is critical to end the epidemic. We describe the underlying factors of unawareness among men aged 15-59 years who ever...